Morphic Holding, Inc. Profile Avatar - Palmy Investing

Morphic Holding, Inc.

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF…
Biotechnology
US, Waltham [HQ]
Major Shareholders · Outstanding & Floating · Short Interest

Share Analysis

Breakdown
Morphic Holding, Inc. can't present any analysts estimates at the moment detail analysis.
Short
Fail To Deliver
Not available for MORF
Shorts Over Time
Not available for MORF
Latest Settlement
Settlement Date n/a
Short Volume $n/a
Change n/a
Short Float n/a
Change n/a
Days to Cover n/a
Change n/a